Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985–2015

Vaccine

Volumn 35, Issue 7, 2017, Pages 997-1000

  Abara, W E ^a   Collier, M G ^a   Teshale, E H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Children; HBsAg; HBV; Hepatitis B vaccination; Hepatitis B virus infection; Pacific Islands

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; CHILD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HEPATITIS B; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PACIFIC ISLANDS; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; VACCINATION; CHRONIC HEPATITIS B; DRUG EFFECTS; ENDEMIC DISEASE; HEPATITIS B VIRUS; IMMUNOLOGY; MASS IMMUNIZATION; PRESCHOOL CHILD; PREVALENCE; STATISTICS AND NUMERICAL DATA; VACCINATION COVERAGE; VIROLOGY;

CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; FEMALE; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MASS VACCINATION; PACIFIC ISLANDS; PREVALENCE; VACCINATION COVERAGE;

EID: 85009801528     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.01.020     Document Type: Article

References (22)

1. [1] Centers for Disease Control and Prevention. Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006–2015. MMWR Morb Mort Wkly Rep.; 2006. 55: 511.
2. [2] Hennessey, K., Mendoza-Aldana, J., Bayutas, B., Lorenzo-Mariano, K.M., Diorditsa, S., Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status. Vaccine 31 (2013), J85–J92.
3. [3] Goldstein, S.T., Zhou, F., Hadler, S.C., Bell, B.P., Mast, E.E., Margolis, H.S., A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34 (2005), 1329–1339.
4. [4] Schweitzer, A., Horn, J., Mikolajczyk, R.T., Krause, G., Ott, J.J., Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386 (2015), 1546–1555.
5. [5] Vogt, T.M., Goldstein, S.T., Kuartei, S., Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990–2002. Trans R Soc Trop Med Hyg 100 (2006), 1130–1134.
6. [6] Lok, A.S., McMahon, B.J., Chronic hepatitis B: update 2009. Hepatol 50 (2009), 661–662.
7. [7] Haddock, R.L., Paulino, Y.C., Bordallo, R., Viral hepatitis and liver cancer on the Island of Guam. Asian Pac J Cancer Prev 14:5 (2013), 3175–3176.
8. [8] Bialek, S.R., Helgenberger, L., Fischer, G.E., Bower, W., Konelios, M., Chaine, J., et al. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the Marshall Islands and the Federated States of Micronesia. Ped Infect Dis J 29 (2010), 18–22.
9. [9] Shepard, C.W., Simard, E.P., Finelli, L., Fiore, A.E., Bell, B.P., Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28 (2006), 112–125.
10. [10] Lok, A.S., Prevention of hepatitis B virus–related hepatocellular carcinoma. Gastroenterology 127 (2004), S303–S309.
11. [11] Venters, C., Graham, W., Cassidy, W., Recombivax-HB: perspectives past, present and future. Exp Rev Vaccines 3 (2004), 119–129.
12. [12] Bruce, M.G., Bruden, D., Hurlburt, D., Zanis, C., Thonpson, G., Rea, L., et al. Antibody levels and protection after hepatitis B vaccine: Results of a 30-year follow-up study and response to a booster dose (epub ahead of print). J Infect Dis, 2016, 10.1093/infdis/jiv748.
13. [13] Mahoney, F.J., Woodruff, B.A., Erben, J.J., Coleman, P.J., Reid, E.C., Schatz, G.C., et al. Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection. J Infect Dis 167 (1993), 203–207.
14. [14] Beasley, R.P., George, C.Y.L., Roan, C.H., Hwang, L.Y., Lan, C.C., Huang, F.Y., et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 322:8359 (1983), 1099–1102.
15. [15] World Health Organization. Preventing mother-to-child transmission of hepatitis B: operational field guidelines for delivery of the birth dose of hepatitis B vaccine. 2006 [cited 2016 Sep 25]. < http://www.wpro.who.int/hepatitis/resource/hepb_operationalfieldguidelines.pdf?ua=1>.
16. [16] Lee, C., Gong, Y., Brok, J., Boxall, E.H., Gluud, C., Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Syst Rev, 2, 2006, 10.1002/14651858.CD004790.pub2.
17. [17] Simons, B.C., Spradling, P.R., Bruden, D.J., Zanis, C., Case, S., Choromanski, T.L., et al. A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B cellular immunity despite loss of antibody against hepatitis B surface antigen (epub ahead of print). J Infect Dis, 2016, 10.1093/infdis/jiw142.
18. [18] Spradling, P.R., Xing, J., Williams, R., Masunu-Faleafaga, Y., Dulski, T., Mahamud, A., et al. Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: association of detectable residual antibodies and response to a single HBV challenge dose. Clin Vaccine Immunol 20 (2013), 559–561.
19. [19] Hawley, N.L., Johnson, W., Hart, C.N., Triche, E.W., Ching, J., Muasau-Howard, B., et al. Gestational weight gain among American Samoan women and its impact on delivery and infant outcomes. BMC Preg Childbirth 15 (2015), 10–17.
20. [20] National Vital Statistics Report. Births: Final data for 2014. 2015 [cited 2016 Sep 25]. < http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_12.pdf>.
21. [21] Hawley, N.L., Brown, C., Nu'usolia, O., Ah-Ching, J., Muasau-Howard, B., McGarvey, S.T., Barriers to adequate prenatal care utilization in American Samoa. Mat Child Health J 18 (2014), 2284–2292.
22. [22] World Health Organization. Practices to improve coverage of the hepatitis B birth dose vaccine; 2013. < http://apps.who.int/iris/bitstream/10665/78616/1/WHO_IVB_12.11_eng.pdf> [cited 2016 Sep 25].